Travis Steed
Stock Analyst at B of A Securities
(3.73)
# 842
Out of 4,412 analysts
55
Total ratings
48.44%
Success rate
7.89%
Average return
Main Sectors:
23 Stocks
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| EW Edwards Lifesciences | Upgrades: Buy | n/a | $86.43 | - | 2 | Mar 7, 2024 | |
| BAX Baxter International | Maintains: Neutral | $42 → $45 | $40.13 | +12.14% | 5 | Mar 5, 2024 | |
| BDX Becton, Dickinson and Company | Maintains: Overweight | $301 → $305 | $231.55 | +31.72% | 5 | Feb 5, 2024 | |
| OM Outset Medical | Downgrades: Underperform | $32 → $3 | $2.40 | +25.00% | 1 | Oct 13, 2023 | |
| SYK Stryker | Upgrades: Buy | $315 | $335.61 | -6.14% | 4 | Sep 5, 2023 | |
| PODD Insulet | Maintains: Buy | $365 → $295 | $166.19 | +77.51% | 3 | Aug 24, 2023 | |
| AXGN AxoGen | Reiterates: Overweight | $16 | $6.63 | +141.33% | 4 | Aug 22, 2023 | |
| SILK Silk Road Medical | Downgrades: Underperform | $51 → $28 | $17.80 | +57.30% | 1 | Jul 12, 2023 | |
| TNDM Tandem Diabetes Care | Downgrades: Underperform | $45 → $33 | $35.24 | -6.36% | 2 | May 5, 2023 | |
| ZBH Zimmer Biomet Holdings | Upgrades: Neutral | $120 → $160 | $119.35 | +34.06% | 5 | May 3, 2023 | |
| ISRG Intuitive Surgical | Maintains: Buy | $300 → $315 | $375.33 | -16.07% | 2 | Apr 19, 2023 | |
| SWAV ShockWave Medical | Maintains: Buy | $335 → $275 | $330.00 | -16.67% | 1 | Apr 11, 2023 | |
| LUNG Pulmonx | Downgrades: Underperform | $8 | $7.28 | +9.89% | 1 | Jan 3, 2023 | |
| EMBC Embecta | Initiates: Underperform | $25 | $10.31 | +142.48% | 1 | Jun 21, 2022 | |
| ABT Abbott Laboratories | Maintains: Buy | $140 | $107.53 | +30.20% | 4 | May 31, 2022 | |
| INMD InMode | Maintains: Overweight | n/a | $17.14 | - | 3 | Oct 13, 2021 | |
| AXNX Axonics | Initiates: Overweight | n/a | $66.69 | - | 1 | Jul 12, 2021 | |
| DXCM DexCom | Initiates: Overweight | n/a | $124.34 | - | 4 | May 25, 2021 | |
| MDT Medtronic | Initiates: Equal-Weight | n/a | $79.74 | - | 1 | May 25, 2021 | |
| BSX Boston Scientific | Initiates: Overweight | n/a | $73.17 | - | 1 | May 25, 2021 | |
| CNMD CONMED | Initiates: Overweight | n/a | $65.78 | - | 1 | May 25, 2021 | |
| IART Integra LifeSciences Holdings | Maintains: Neutral | n/a | $28.34 | - | 2 | Nov 1, 2018 | |
| LNTH Lantheus Holdings | Initiates: Overweight | n/a | $65.56 | - | 1 | Jul 17, 2017 |
Edwards Lifesciences
Mar 7, 2024
Upgrades: Buy
Price Target: n/a
Current: $86.43
Upside: -
Baxter International
Mar 5, 2024
Maintains: Neutral
Price Target: $42 → $45
Current: $40.13
Upside: +12.14%
Becton, Dickinson and Company
Feb 5, 2024
Maintains: Overweight
Price Target: $301 → $305
Current: $231.55
Upside: +31.72%
Outset Medical
Oct 13, 2023
Downgrades: Underperform
Price Target: $32 → $3
Current: $2.40
Upside: +25.00%
Stryker
Sep 5, 2023
Upgrades: Buy
Price Target: $315
Current: $335.61
Upside: -6.14%
Insulet
Aug 24, 2023
Maintains: Buy
Price Target: $365 → $295
Current: $166.19
Upside: +77.51%
AxoGen
Aug 22, 2023
Reiterates: Overweight
Price Target: $16
Current: $6.63
Upside: +141.33%
Silk Road Medical
Jul 12, 2023
Downgrades: Underperform
Price Target: $51 → $28
Current: $17.80
Upside: +57.30%
Tandem Diabetes Care
May 5, 2023
Downgrades: Underperform
Price Target: $45 → $33
Current: $35.24
Upside: -6.36%
Zimmer Biomet Holdings
May 3, 2023
Upgrades: Neutral
Price Target: $120 → $160
Current: $119.35
Upside: +34.06%
Intuitive Surgical
Apr 19, 2023
Maintains: Buy
Price Target: $300 → $315
Current: $375.33
Upside: -16.07%
ShockWave Medical
Apr 11, 2023
Maintains: Buy
Price Target: $335 → $275
Current: $330.00
Upside: -16.67%
Pulmonx
Jan 3, 2023
Downgrades: Underperform
Price Target: $8
Current: $7.28
Upside: +9.89%
Embecta
Jun 21, 2022
Initiates: Underperform
Price Target: $25
Current: $10.31
Upside: +142.48%
Abbott Laboratories
May 31, 2022
Maintains: Buy
Price Target: $140
Current: $107.53
Upside: +30.20%
InMode
Oct 13, 2021
Maintains: Overweight
Price Target: n/a
Current: $17.14
Upside: -
Axonics
Jul 12, 2021
Initiates: Overweight
Price Target: n/a
Current: $66.69
Upside: -
DexCom
May 25, 2021
Initiates: Overweight
Price Target: n/a
Current: $124.34
Upside: -
Medtronic
May 25, 2021
Initiates: Equal-Weight
Price Target: n/a
Current: $79.74
Upside: -
Boston Scientific
May 25, 2021
Initiates: Overweight
Price Target: n/a
Current: $73.17
Upside: -
CONMED
May 25, 2021
Initiates: Overweight
Price Target: n/a
Current: $65.78
Upside: -
Integra LifeSciences Holdings
Nov 1, 2018
Maintains: Neutral
Price Target: n/a
Current: $28.34
Upside: -
Lantheus Holdings
Jul 17, 2017
Initiates: Overweight
Price Target: n/a
Current: $65.56
Upside: -